|
WO2016121512A1
|
|
Method for preparing bone marrow cell aggregate
|
|
SG11201606750UA
|
|
Method for generating cell condensate for self-organization
|
|
WO2015137056A1
|
|
Prevention or treatment of patent ductus arteriosus by glutamic acid
|
|
WO2015119132A1
|
|
Method for predicting progression of pre-cancerous lesion
|
|
WO2015083779A1
|
|
Coffin-siris syndrome detection method
|
|
WO2015005110A1
|
|
Temporary vertebral immobilization implement and temporary vertebral immobilization implement unit
|
|
WO2014199944A1
|
|
Method for detecting intractable epilepsy accompanying severe intellectual disability and motor development retardation
|
|
WO2014188994A1
|
|
Method for amplifying cell using amino acid preparation
|
|
WO2014080979A1
|
|
Method for detecting neurological disease accompanied by inflammation and/or demyelination
|
|
WO2014027615A1
|
|
Method for detecting mitochondrial complex iii deficiency patients or carriers
|
|
WO2013103094A1
|
|
Method for detecting coffin-siris syndrome
|
|
WO2013089123A1
|
|
Gene targeting vector, and method for using same
|
|
EP2762000A1
|
|
Method for inducing hepatocellular variation, and production method for chimeric non-human animal having humanized liver
|
|
WO2013047639A1
|
|
Method for producing tissue and organ
|
|
WO2013047677A1
|
|
Linear amplification method for trace dna fragment
|
|
WO2013051330A1
|
|
Treatment of atrial fibrillation by means of vidarabine
|
|
WO2013015152A1
|
|
TECHNIQUE FOR CLEAVING OUT PART OF poly(A) CHAIN AND/OR 3'-TERMINAL SEQUENCE OF mRNA TO INHIBIT TRANSLATION REACTION
|
|
WO2013005603A1
|
|
Agent for prevention and/or treatment of allergic inflammation in conjunctiva
|
|
EP2719759A1
|
|
Production method for artificial cancer stem cell and induced differentiation method therefor
|
|
EP2716759A1
|
|
Gene targeting vector, method for manufacturing same, and method for using same
|
